Sierra Oncology
Targeted Cancer Therapies using DNAi.
Launch date
Employees
Market cap
-
Enterprise valuation
€216—325m (Dealroom.co estimates Apr 2014.)
Kalamazoo Michigan (HQ)
Financials
Estimates*
| EUR | 2015 |
|---|---|
| R&D budget | 24.0m |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $2.7m | Debt | |
| N/A | N/A | IPO | |
| N/A | $103m | Post IPO Equity | |
| N/A | $34.0m | Post IPO Equity | |
| N/A | $135m | Secondary | |
| Total Funding | €71.0m | ||
Related Content
Recent News about Sierra Oncology
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.